Why We Chose Our Beneficiaries
We’ve purposefully selected the beneficiaries of the Défi Canderel cancer research fundraiser with a profound vision in mind: to unite researchers, inspire collaboration, and be catalysts in combatting cancer.
We firmly believe that collaboration, not competition, is the key to unlocking breakthroughs in cancer research.
We support both francophone and anglophone university research centres because we believe diversity is a powerful force for change.
By facilitating the exchange of knowledge, ideas, and resources, we empower these institutions to work together harmoniously towards one common goal – ending cancer.
These world-renowned academic research centres nurture a new generation of passionate, innovative researchers. They represent the future of cancer research, and investing in their bold initiatives is our way of accelerating progress.
By supporting these visionary researchers, we are achieving faster and more effective results in our quest to eliminate the devastating impact of cancer.
Join us in supporting innovation to make a difference by bringing hope to countless lives.
Montreal Cancer Institute
Focused on advancing cancer prevention, screening, treatment, and improving patients’ quality of life, the Montreal Cancer Institute, affiliated with the CRCHUM’s Cancer Research Axis and the Université de Montréal, has been supporting research for over 75 years, through:
- Innovative projects
- Recruiting and training young researchers
- Educational initiatives
The Institut du cancer de Montréal (ICM) leverages funds from Défi Canderel to promote fundamental and clinical cancer research while preparing the next generation of researchers.
Give researchers the means to beat cancer by supporting research projects, contributing to the purchase of state-of-the-art equipment, awarding scholarships, and helping to organise scientific conferences.
To financially support excellence in research related to the Cancer Axis of the Centre de recherche du Centre hospitalier de l’Université de Montréal (CRCHUM).
Commitment, Collaboration, Integrity, Excellence, and Entrepreneurship.
DVM, PhD, FCAHS
Director of research and innovation, CHUM
Rosalind and Morris Goodman
Through its dedication to interdisciplinary cancer research and fostering a vibrant culture of creativity and collaboration among experts, the GCI advances cancer research by:
- Funding high-risk-high-payoff studies to provide early data needed to win competitive grants
- Recruiting new faculty with innovative research programs
- Providing students with funding to focus on research
- Helping students share their findings at conferences worldwide
With a focus on educating and training the next generation of leaders, the Rosalind and Morris Goodman Cancer Institute (GCI) leverages funds from Défi Canderel to recruit top global talent and discover breakthroughs in cancer treatment, prevention, and well-being.
Build a renowned world-class community of researchers committed to improving outcomes for cancer patients through scientific excellence.
Understand what drives cancer in order to better prevent, diagnose and treat the disease.
Integrity, Creativity, Collaboration and Commitment.
Dr. Morag Park
Director, Rosalind and Morris Goodman Cancer Centre